Inactive Instrument

CORIUM Stock Nasdaq

Stocks

Pharmaceuticals

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Press Releases: CORIUM

27/01/20	Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease	GL
02/04/19	Corium Appoints Perry Sternberg as Chief Executive Officer	GL
17/12/18	Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025	GL
15/10/18	Corium International : RM LAW Announces Investigation of Corium International, Inc.	PR
12/10/18	CORIUM INTERNATIONAL, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU

More press releases

Managers and Directors: CORIUM

Manager	Title	Age	Since
Todd Smith CEO	Chief Executive Officer	57	-
Ben Bove DFI	Director of Finance/CFO	-	-
Steven N. Gersten CMP	Compliance Officer	-	-

Director	Title	Age	Since
Travis Wilson BRD	Director/Board Member	-	27/11/2018
Sophie Kornowski-Bonnet CHM	Chairman	63	-
David Moore BRD	Director/Board Member	52	-

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	-1.37%	+8.90%	+91.28%	+130.00%	1,083B
	JOHNSON & JOHNSON	-0.77%	+1.91%	+49.46%	+49.44%	626B
	ABBVIE INC.	+0.85%	+2.58%	+25.90%	+64.34%	442B
	ROCHE HOLDING AG	-1.13%	+3.13%	+49.78%	+39.13%	363B
	NOVARTIS AG	-0.74%	+1.01%	+31.08%	+38.64%	295B
	ASTRAZENECA PLC	-1.22%	+0.89%	+7.32%	+7.38%	248B
	AMGEN INC.	-0.70%	+6.23%	+45.32%	+57.82%	224B
	NOVO NORDISK A/S	+0.34%	-0.13%	-4.77%	-50.50%	210B
	GILEAD SCIENCES, INC.	+2.04%	+0.38%	+12.70%	+69.71%	168B
	Average	-0.30%	+1,662.85%	+34.23%	+45.11%	406.57B
	Weighted average by Cap.	-0.62%	+1,332.62%	+49.63%	+66.05%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

As early as today, start finding the best investment opportunities!